Related Experiment Video
Updated: Jan 3, 2026
07:31
Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
7.5K
The RxHL study: community-responsive research to explore barriers to medication adherence
Susan J Shaw1, Josephine D Korchmaros2, Cristina Huebner Torres3
1Department of Health Promotion and Policy, School of Public Health and Health Sciences, University of Massachusetts, Amherst, MA 01002, USA.
Health Education Research
|November 27, 2019
Summary
Community-based research methods improved medication adherence in diverse, low-income patients. This approach addressed barriers like cost and transportation, enhancing chronic disease management through collaboration.
Area of Science:
- Community-based participatory research
- Health services research
- Mixed-methods research
Background:
- Developing community-responsive research is crucial for addressing health disparities.
- Federally Qualified Health Centers (FQHCs) serve diverse, low-income populations with chronic diseases.
- Effective medication adherence strategies require understanding patient-centered barriers.
Purpose of the Study:
- To describe the mixed-methods research approach of the RxHL study.
- To highlight interprofessional and community-based collaboration in research design.
- To assess factors influencing medication adherence in a diverse, low-income patient population.
Main Methods:
- Employed a mixed-methods design, integrating quantitative (chart review, pill counts, surveys) and qualitative (interviews, home visits, diaries) data.
- Utilized constant comparison and interdisciplinary team meetings for data integration.
- Engaged in close consultation with FQHC staff and providers throughout the study.
Main Results:
- A community-responsive approach facilitated recruitment and retention of a diverse patient sample.
- Quantitative data identified barriers such as medication costs, transportation, and limited health literacy.
- Qualitative data provided deeper insights into the social and environmental contexts affecting adherence.
Conclusions:
- Prioritizing community partner and participant needs enhances data rigor and participation.
- Mixed-methods research, informed by community collaboration, effectively identifies adherence barriers.
- This approach supports the development of responsive and effective healthcare interventions for chronic disease management.
Related Concept Videos
01:28Drug Therapy
220
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
220
01:15Drug Dosing: Geriatric Patients
189
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
189
01:19Pharmacovigilance
1.5K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.5K
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
113
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
113
01:21Factors Affecting Drug Response: Overview
2.8K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.8K
01:28Dosage Regimens: Designs and Approaches
220
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
220